From the Journals

Collagenase Effective for Recurrent Dupuytren

Collagenase treatment improves contracture recurrence in patients after prior surgery

Share

  • 1

    CCH is a non-surgical therapy option for recurrent Dupuytren contracture.

  • 2

    Study included 101 patients with a mean age of

  • 3

    Recurrence of symptoms occurred at a median of 36 months post-surgery.

  • 4

    Average baseline contracture was 52°.

  • 5

    Clinical success at final evaluation was 58%.

  • 6

    Most common adverse event was skin tears (19%).

  • 7

    CCH improves joint extension significantly after treatment.

  • 8

    Less complication risk compared to repeat surgery.

Original Source(s)

Collagenase Effective for Recurrent Dupuytren

Collagenase treatment improves contracture recurrence in patients after prior surgery

  • by Alun Evans

  • March 11, 2026

  • 3 min

Related Content

CYP2D6 Testing and Postoperative Opioids

Investigators evaluate whether genotype-guided prescribing improves postoperative pain management.

Miami Neuroscience Institute’s Program at Baptist Health South Miami Hospital Earns Advanced Spine Surgery Certification

The Spine Program at South Miami Hospital has achieved The Joint Commission’s Advanced Certification for Spine Surgery.

  • by

  • March 4, 2026

  • 2 min
Motion Preservation in the Lumbar Spine: Total Joint Replacement Restores Function in a 35-Year-Old Patient

While several physicians had recommended spinal fusion surgery, Frank Vrionis, M.D., Ph.D., neurosurgeon and chief of surgery at Marcus Neuroscience Institute at Boca Raton Regional Hospital, part of Baptist Health, took a different approach.

  • by

  • March 3, 2026

  • 4 min